Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025

Group 1 - Medtronic plc (NYSE:MDT) is recognized as a strong candidate for a dividend stock portfolio, emphasizing its long-standing commitment to dividend growth [2][4] - The company has faced challenges but is focusing on improving profitability, including the separation of its diabetes care segment, which is expected to enhance earnings [2][3] - Medtronic remains a major player in the medical device industry, with solid core operations and ongoing innovation driving revenue and profit growth [3][4] Group 2 - Medtronic has achieved 48 consecutive years of dividend growth, positioning it just 2 years away from becoming a Dividend King [4] - The company currently offers a quarterly dividend of $0.71 per share, resulting in a dividend yield of 2.98% as of September 18 [4]